This trial is active, not recruiting.

Condition external causes of morbidity and mortality
Sponsor Ruhr University of Bochum
Start date August 2015
End date February 2016
Trial size 271 participants
Trial identifier NCT02641977, 19802015


Longterm followup of patients with rheumatoid arthritis 30 years after starting a baseline treatment with Methotrexate.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

time frame: 30 years

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - rheumatoid arthritis - treatment with methotrexate - active disease Exclusion Criteria: - low disease activity - previous treatment with methotrexate

Additional Information

Official title Longterm Followup of Patients With Rheumatoid Arthritis Treated With Methotrexate Enroled in the Ratingener Rheuma-Kohorte
Principal investigator Dietmar MJ Krause, MD
Trial information was received from ClinicalTrials.gov and was last updated in December 2015.
Information provided to ClinicalTrials.gov by Ruhr University of Bochum.